The challenge of regenerative therapies for the optic nerve in glaucoma.
about
Astrocyte-derived lipoxins A4 and B4 promote neuroprotection from acute and chronic injury.Tenascins in Retinal and Optic Nerve Neurodegeneration.CD200Fc Attenuates Retinal Glial Responses and RGCs Apoptosis After Optic Nerve Crush by Modulating CD200/CD200R1 Interaction.In Vivo Small Molecule Delivery to the Optic Nerve in a Rodent Model.Pluripotent Stem Cell-Based Approaches to Explore and Treat Optic Neuropathies
P2860
The challenge of regenerative therapies for the optic nerve in glaucoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The challenge of regenerative therapies for the optic nerve in glaucoma.
@en
The challenge of regenerative therapies for the optic nerve in glaucoma.
@nl
type
label
The challenge of regenerative therapies for the optic nerve in glaucoma.
@en
The challenge of regenerative therapies for the optic nerve in glaucoma.
@nl
prefLabel
The challenge of regenerative therapies for the optic nerve in glaucoma.
@en
The challenge of regenerative therapies for the optic nerve in glaucoma.
@nl
P2093
P2860
P1476
The challenge of regenerative therapies for the optic nerve in glaucoma.
@en
P2093
David J Calkins
Larry Benowitz
Lasker/IRRF Initiative on Astrocytes and Glaucomatous Neurodegeneration Participants
Melissa L Cooper
Milos Pekny
P2860
P356
10.1016/J.EXER.2017.01.007
P577
2017-01-30T00:00:00Z